The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
A bullish flag pattern has emerged in the chart of Dexcom Inc. (DXCM), where the stock is just under a resistance line. If DXCM breaks through this level, a breakout could occur. Read more if you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results